Financials Nature's Sunshine Products, Inc.

Equities

NATR

US6390271012

Food Processing

Real-time Estimate Cboe BZX Other stock markets 01:49:08 2025-06-12 pm EDT			5-day change	1st Jan Change
14.32 ^USD	+0.67%		-1.92%	-2.59%

Jun. 09	Nature's Sunshine Products files for offering of 2.8 mln shares	RE
Jun. 02	Terrence Moorehead to Step Down as Chief Executive Officer of Nature?s Sunshine Products, Inc	CI

Projected Income Statement: Nature's Sunshine Products, Inc.

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	385.2	444.1	421.9	445.3	454.4	459.2	470.2
Change	-	15.29%	-4.99%	5.55%	2.03%	1.06%	2.41%
EBITDA ¹	-	49.42	32.03	40.42	40.54	42.55	46.77
Change	-	-	-35.19%	26.2%	0.3%	4.95%	9.91%
EBIT ¹	-	34.53	18.1	23.71	21.54	22.33	25.74
Change	-	-	-47.57%	30.98%	-9.17%	3.66%	15.28%
Interest Paid	-	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	-	-	-	-	18.43	23.09	25.74
Change	-	-	-	-	-	25.33%	11.45%
Net income ¹	-	-	-0.39	15.08	7.696	14.64	16.25
Change	-	-	-	3,965.64%	-48.95%	90.28%	10.94%
Announcement Date	3/10/21	3/8/22	3/15/23	3/12/24	3/11/25	-	-

¹USD in Million

Estimates

Fiscal Period: December	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales ¹	109	114.7	117.9	110.5	104.2	104.5	102.7	108.6	116.5	111.2	108.9	111	110.6	114.6	118.2	113.2	113.1	116.7	116.2	117	116	119.7	119.7
Change	-	5.29%	2.78%	-6.31%	-5.73%	0.33%	-1.68%	5.73%	7.29%	-4.59%	-2.04%	1.89%	-0.4%	3.68%	3.13%	-4.19%	-0.15%	3.19%	-0.45%	0.72%	-0.85%	3.19%	0%
EBITDA ¹	-	12.94	11.57	8.183	8.98	6.836	8.031	9.133	11.31	10.25	9.729	9.153	10.4	10.73	10.27	10.97	10.03	10.75	10.78	12.2	9.7	11	12.2
Change	-	-	-10.57%	-29.29%	9.74%	-23.88%	17.48%	13.72%	23.8%	-9.33%	-5.1%	-5.92%	13.59%	3.17%	-4.29%	6.86%	-8.58%	7.22%	0.25%	13.16%	-20.49%	13.4%	10.91%
EBIT ¹	-	10.01	7.912	4.616	5.755	5.012	4.151	5.27	7.037	5.832	5.573	4.624	5.637	6.241	5.035	6.172	4.968	5.76	5.411	7.1	4.4	6.1	6.5
Change	-	-	-20.93%	-41.66%	24.68%	-12.91%	-17.18%	26.96%	33.53%	-17.12%	-4.44%	-17.03%	21.91%	10.71%	-19.32%	22.58%	-19.51%	15.96%	-6.07%	31.21%	-38.03%	38.64%	6.56%
Charge d'intérêts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	-	9.12	6.985	0.995	5.313	2.731	6.176	-	-	-	7.661	4.655	4.423	7.899	1.449	7.109	5.068	5.86	5.511	7.1	4.4	6.1	6.5
Change	-	-	-23.41%	-85.76%	433.97%	-48.6%	126.14%	-	-	-	-	-39.24%	-4.98%	78.59%	-81.66%	390.61%	-28.72%	15.65%	-5.96%	28.83%	-38.03%	38.64%	6.56%
Net income ¹	-	4.858	13.44	-2.95	0.516	0.09	1.954	0.86	2.422	2.832	8.962	2.321	1.349	4.347	-0.321	4.747	3.126	3.534	3.71	4.4	2.7	3.6	4.6
Change	-	-	176.64%	-121.95%	117.49%	-82.56%	2,071.11%	-55.99%	181.63%	16.93%	216.45%	-74.1%	-41.88%	222.24%	-107.38%	1,578.82%	-34.14%	13.04%	4.96%	18.61%	-38.64%	33.33%	27.78%
Announcement Date	8/5/21	11/4/21	3/8/22	5/5/22	8/9/22	11/3/22	3/15/23	5/9/23	8/9/23	11/7/23	3/12/24	5/7/24	8/8/24	11/7/24	3/11/25	5/6/25	-	-	-	-	-	-	-

¹USD in Million

Estimates

Forecast Balance Sheet: Nature's Sunshine Products, Inc.

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026
Net Debt	-	-83.5	-58.9	-82.4	-84.7	-	-
Change	-	-	29.46%	-39.9%	-2.79%	-	-
Announcement Date	3/10/21	3/8/22	3/15/23	3/12/24	3/11/25	-	-

Estimates

Cash Flow Forecast: Nature's Sunshine Products, Inc.

Fiscal Period: December	2021	2022	2023	2024	2025	2026
CAPEX ¹	6.666	7.628	10.48	10.97	11.5	12.1
Change	-	14.43%	37.36%	4.71%	4.82%	5.22%
Free Cash Flow (FCF) ¹	8.084	-11.04	29.91	11.19	23.1	25.1
Change	-	-236.5%	371.06%	-62.6%	106.51%	8.66%
Announcement Date	3/8/22	3/15/23	3/12/24	3/11/25	-	-

¹USD in Million

Estimates

Forecast Financial Ratios: Nature's Sunshine Products, Inc.

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Profitability
EBITDA Margin (%)	-	-	11.13%	7.59%	9.08%	8.92%	9.27%	9.95%
EBIT Margin (%)	-	-	7.77%	4.29%	5.32%	4.74%	4.86%	5.47%
EBT Margin (%)	-	-	-	-	-	4.06%	5.03%	5.47%
Net margin (%)	-	-	-	-0.09%	3.39%	1.69%	3.19%	3.46%
FCF margin (%)	-	-	1.82%	-2.62%	6.72%	2.46%	5.03%	5.34%
FCF / Net Income (%)	-	-	-	2,829.49%	198.41%	145.35%	157.74%	154.5%
Profitability
ROA	4.96%	5.81%	8.52%	4.16%	6.37%	5.12%	-	-
ROE	5.54%	16.02%	18.96%	0.36%	10.71%	4.92%	-	-
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	-	1.5%	1.81%	2.35%	2.41%	2.5%	2.57%
CAPEX / EBITDA (%)	-	-	13.49%	23.82%	25.92%	27.06%	27.03%	25.87%
CAPEX / FCF (%)	-	-	82.46%	-69.13%	35.03%	98.08%	49.78%	48.21%
Items per share
Cash flow per share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
EPS ¹	-	1.07	1.42	-0.02	0.77	0.4	0.775	0.86
Change	-	-	32.71%	-101.41%	3,950%	-48.05%	93.75%	10.97%
Nbr of stocks (in thousands)	-	19,658	19,761	19,167	19,075	18,476	18,351	18,351
Announcement Date	-	3/10/21	3/8/22	3/15/23	3/12/24	3/11/25	-	-